全球G蛋白偶聯受體市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

G 蛋白偶聯受體 (GPCR) 市場預計將從 2025 年的 42.8 億美元成長到 2034 年的 76.5 億美元，預計從 2026 年到 2034 年將以 6.67% 的複合年成長率成長。

由於G蛋白偶聯受體（GPCR）在藥物發現和開發中發揮至關重要的作用，全球GPCR市場正經歷顯著成長。 GPCR是最大的藥物標靶類別之一，影響著廣泛的生理過程。癌症、心血管疾病和神經系統疾病等慢性疾病的日益普遍，正在加速以GPCR為基礎的療法的研究活動。

關鍵促進因素包括分子生物學、生物資訊學和高通量篩檢技術的進步，這些技術能夠有效地識別GPCR靶點。製藥公司正大力投資研發，以開發針對這些受體的新型藥物。此外，學術機構和生技公司之間日益密切的合作正在加速創新，並擴大GPCR的應用範圍。

隨著人工智慧和電腦輔助藥物發現技術的融合，市場預計未來將持續成長。個人化醫療和標靶治療將進一步推動對基於G蛋白偶聯受體（GPCR）藥物的需求。隨著研究不斷揭示新的受體功能，市場將保持高度活力，為治療方法的創新和進步提供巨大的機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球G蛋白偶聯受體市場：依產品分類

• 市場分析、洞察與預測
• 細胞株
• 檢測套件
• 細胞培養試劑
• 配體

第5章 全球G蛋白偶聯受體市場：依檢測類型分類

• 市場分析、洞察與預測
• cAMP功能偵測
• 鈣功能測定
• BETA-arrestin功能測定
• 放射性配體結合試驗和GTPY功能試驗
• 內化試驗
• 交通分析
• 其他檢測

第6章：全球G蛋白偶聯受體市場：依應用分類

• 市場分析、洞察與預測
• 癌症調查
• 中樞神經系統調查
• 代謝研究
• 心血管檢查
• 呼吸系統檢查
• 炎症調查
• 其他用途

第7章 全球G蛋白偶聯受體市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Eurofins Scientific
  • QIAGEN
  • WuXi AppTec
  • Promega Corporation
  • Abcam Plc
  • Merck KGaA
  • PerkinElmer Inc
  • Enzo Biochem Inc
  • BD

The G-Protein Coupled Receptors Market size is expected to reach USD 7.65 Billion in 2034 from USD 4.28 Billion (2025) growing at a CAGR of 6.67% during 2026-2034.

The global G-protein coupled receptors (GPCR) market is witnessing significant growth due to its critical role in drug discovery and development. GPCRs represent one of the largest classes of drug targets, influencing a wide range of physiological processes. Increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has accelerated research activities focused on GPCR-based therapeutics.

Key drivers include advancements in molecular biology, bioinformatics, and high-throughput screening technologies that enable efficient identification of GPCR targets. Pharmaceutical companies are heavily investing in R&D to develop novel drugs targeting these receptors. Additionally, growing collaborations between academic institutions and biotech firms have enhanced innovation and expanded the application scope of GPCRs.

Looking ahead, the market is expected to grow with the integration of artificial intelligence and computational drug design techniques. Personalized medicine and targeted therapies will further boost demand for GPCR-based drugs. As research continues to uncover new receptor functions, the market will remain highly dynamic, offering significant opportunities for innovation and therapeutic advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Cell Lines
• Detection Kits
• Cell Culture Reagents
• Ligands

By Assay Type

• cAMP Functional Assays
• Calcium Functional Assays
• B-Arrestin Functional Assays
• Radioligand Binding & GTPYS Functional Assays
• Internalization Assays
• Trafficking Assays
• Other Assays

By Application

• Cancer Research
• CNS Research
• Metabolic Research
• Cardiovascular Research
• Respiratory Research
• Inflammation Research
• Other Applications

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Eurofins Scientific, QIAGEN, WuXi AppTec, Promega Corporation, Abcam plc, Merck KGaA, PerkinElmer Inc, Enzo Biochem Inc, BD
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Cell Lines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Detection Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cell Culture Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Ligands Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET: BY ASSAY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Assay Type
• 5.2. cAMP Functional Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Calcium Functional Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. B-Arrestin Functional Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Radioligand Binding & GTPYS Functional Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Internalization Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Trafficking Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CNS Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Metabolic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Respiratory Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Inflammation Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Assay Type
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Assay Type
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Assay Type
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Assay Type
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Assay Type
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL G-PROTEIN COUPLED RECEPTORS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Eurofins Scientific
  • 9.2.3 QIAGEN
  • 9.2.4 WuXi AppTec
  • 9.2.5 Promega Corporation
  • 9.2.6 Abcam Plc
  • 9.2.7 Merck KGaA
  • 9.2.8 PerkinElmer Inc
  • 9.2.9 Enzo Biochem Inc
  • 9.2.10 BD